← Open Payments lookup

KATELYN SCHWARTZ: Open Payments

NPI 1144971185 · ORANGE CITY, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,385 in 55 payments from 14 companies in 2025. Trend: 2023 $0 · 2024 $595 · 2025 $1,385

Food & beverage: $1,334Education: $51
CompanyPaymentsAmount
Madrigal Pharmaceuticals10$239
Takeda Pharmaceuticals U.S.A., Inc.13$231
Janssen Biotech, Inc.8$164
Ipsen Biopharmaceuticals, Inc1$143
Intercept Pharmaceuticals, Inc.4$132
ABBVIE INC.4$103
Phathom Pharmaceuticals, Inc.2$78
Salix Pharmaceuticals, a division of Bausch Health US, LLC3$58
GENZYME CORPORATION3$57
Celltrion USA Inc.2$51

Products named: REZDIFFRA, TREMFYA, ENTYVIO, IQIRVO, OCALIVA, DUPIXENT, VOQUEZNA, RINVOQ.

Industry payments across FL — which companies pay providers there.